Objective: The main objective of the present work to evaluate the theraputic potential of standardized aqueous extract of E. littorale blume(Mamajjaka) in Metabolic Syndrome (MS) patients.

Design: Single blind clinical trial

Methodology: In this present study, total 50 (N=50) previously diagnosed MS patients were randomly selected and divided into two groups having 25 patients in each group. In group I (n=25) patient have advised to take starch capsule 500mg TID as a placebo and in Group II (n=25) standardized aqueous extract of E. littorale blume(Mamajjaka) 500mg TID has been given for 3 month with follow up of 1 month. During the entire course of therapy patients were advised to continue their ongoing conventional treatment along with trial drug.

Result: Statistical analysis showed significant improvement in dyslipidemic state and hyperglycemic state of MS patient as compared to placebo group.

Conclusion: The aqueous extract of E. littorale blume(Mamajjaka) exhibit excellent hypolipidemic and hypoglycemic potential in MS patients